{"id":165514,"date":"2023-06-10T20:24:19","date_gmt":"2023-06-11T01:24:19","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/06\/developing-new-nanoparticle-treatments-for-brain-tumors"},"modified":"2023-06-10T20:24:19","modified_gmt":"2023-06-11T01:24:19","slug":"developing-new-nanoparticle-treatments-for-brain-tumors","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/06\/developing-new-nanoparticle-treatments-for-brain-tumors","title":{"rendered":"Developing new nanoparticle treatments for brain tumors"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/developing-new-nanoparticle-treatments-for-brain-tumors.jpg\"><\/a><\/p>\n<p>Northwestern Medicine investigators have developed a novel nanoparticle treatment for glioblastoma, according to a study published in Nature Communications.<\/p>\n<p>Glioblastoma, the most common type of primary brain cancer, is one of the most complex, deadly and treatment-resistant cancers, according to the National Brain Tumor Society. The five-year survival rate for <a href=\"https:\/\/phys.org\/tags\/glioblastoma\/\" rel=\"tag\" class=\"\">glioblastoma<\/a> patients hovers near 7% and has remained unchanged for decades.<\/p>\n<p>Previous Northwestern Medicine <a href=\"https:\/\/www.pnas.org\/doi\/full\/10.1073\/pnas.1906346116\">research<\/a> has shown that glioblastoma tumors accumulate large numbers of immunosuppressive tumor-associated <a href=\"https:\/\/phys.org\/tags\/myeloid+cells\/\" rel=\"tag\" class=\"\">myeloid cells<\/a> (TAMCs), which impairs the immune system\u2019s ability to fight the tumor and reduces the effectiveness of radiation and chemotherapy.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Northwestern Medicine investigators have developed a novel nanoparticle treatment for glioblastoma, according to a study published in Nature Communications. Glioblastoma, the most common type of primary brain cancer, is one of the most complex, deadly and treatment-resistant cancers, according to the National Brain Tumor Society. The five-year survival rate for glioblastoma patients hovers near 7% [\u2026]<\/p>\n","protected":false},"author":661,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,4,47],"tags":[],"class_list":["post-165514","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-nanotechnology","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/165514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/661"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=165514"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/165514\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=165514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=165514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=165514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}